Meningioma 1 anticorps (Middle Region)

N° du produit ABIN953469

Détail du produit anti-Meningioma 1 anticorps

Antigène: Meningioma 1 (MN1) (MN1 proto-oncogene (MN1))

Épitope: AA 842-872, Middle Region

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp Meningioma 1 est non-conjugé

Application: Western Blotting (WB), Enzyme Immunoassay (EIA)

Specificité: This antibody recognizes Human MN1 (Center).

Purification: Protein A column, followed by peptide affinity purification

Immunogène: KLH conjugated synthetic peptide between 842-872 amino acids from the Central region of human MN1.

Isotype: Ig Fraction

Information d'application

Indications d'application: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 0.25 mg/mL

Buffer: PBS containing 0.09 % (W/V) Sodium Azide as preservative

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Conseil sur la manipulation: Avoid repeated freezing and thawing.

Stock: 4 °C/-20 °C

Stockage commentaire: Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.

Détails sur Meningioma 1

Antigène: Meningioma 1 (MN1) (MN1 proto-oncogene (MN1))

Autre désignation: MN1 (MN1 Produits)

Synonymes: anticorps MGCR, anticorps MGCR1, anticorps MGCR1-PEN, anticorps dJ353E16.2, anticorps MN1 proto-oncogene, transcriptional regulator, anticorps MN1

Sujet: Meningioma 1 (MN1) contains two sets of CAG repeats. It is disrupted by a balanced translocation (4,22) in a meningioma, and its inactivation may contribute to meningioma 32 pathogenesis.Synonyms: Probable tumor suppressor protein MN1, meningioma 1

Poids moléculaire: 136001 Da

ID gène: 4330

NCBI Accession: NP_002421